COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,971 Articles (22,604 medRxiv, 8,367 bioRxiv)

Most recent first Previous |  Page 2253: Articles 22521-22530  | Next

Immunological characteristics govern the changing severity of COVID-19 during the transition to endemicity
Lavine, J. S., Bjornstad, O. N., Antia, R.
10.1101/2020.09.03.20187856 — Posted: 2020-09-05
Swab pooling for large-scale RT-qPCR screening of SARS-CoV-2
Christoff, A. P., Cruz, G. N. F., Sereia, A. F. R., Boberg, D. R., de Bastiani, D. C., Yamanaka, L. E., Fongaro, G., Stoco, P. H., Bazzo, M. L., Grisard, E. C., Hernandes, C., de Oliveira, L. F. V.
10.1101/2020.09.03.20187732 — Posted: 2020-09-05 Discussion: Onsite
Viable virus aerosol propagation by PAP circuit leak and mitigation with a ventilated patient hood: a model for improving health care worker safety in the COVID-19 pandemic
Landry, S. A., Barr, J., MacDonald, M., Subedi, D., Mansfield, D., Hamilton, G., Edwards, B., Joosten, S.
10.1101/2020.09.04.20187922 — Posted: 2020-09-05
Assessment of COVID-19 Pandemic in Nepal: A Lockdown Scenario Analysis
Parajuli, K. S., Banstola, A., Parajuli, R. R.
10.1101/2020.09.03.20187807 — Posted: 2020-09-05
COVID-19 hospitalizations in Brazil's Unified Health System (SUS)
de Andrade, C. L. T., Pereira, C. C. d. A., Martins, M., Lima, S. M. L., Portela, M. C.
10.1101/2020.09.03.20187617 — Posted: 2020-09-05
FEASIBILITY OF ESTABLISHING A RETURN-TO-WORK PROTOCOL BASED ON COVID-19 ANTIBODIES TESTING
Job, G., Okungbowa-Ikponmwosa, J., Mu, Y.
10.1101/2020.09.03.20187823 — Posted: 2020-09-05
SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19
Britton, G. J., Chen-Liaw, A., Cossarini, F., Livanos, A. E., Spindler, M. P., Plitt, T., Eggers, J., Mogno, I., Gonzalez-Reiche, A., Siu, S., Tankelevich, M., Grinspan, L., Dixon, R. E., Jha, D., Martinez-Delgado, G., Amanat, F., Hoagland, D. A., tenOever, B., Dubinsky, M. C., Merad, M., van Bakel, H., Krammer, F., Bongers, G., Mehandru, S., Faith, J. J.
10.1101/2020.09.03.20183947 — Posted: 2020-09-05
Household Secondary Attack Rate in Gandhinagar district of Gujarat state from Western India
Shah, K., Desai, N., Saxena, D., Mavalankar, D., Mishra, U., Patel, G. C.
10.1101/2020.09.03.20187336 — Posted: 2020-09-05
Impact of baseline cases of cough and fever on UK COVID-19 diagnostic testing rates: estimates from the Bug Watch community cohort study
Eyre, M. T., Burns, R., Kirkby, V., Smith, C., Denaxas, S., Nguyen, V., Hayward, A., Shallcross, L., Fragaszy, E., Aldridge, R. W.
10.1101/2020.09.03.20187377 — Posted: 2020-09-05
Adjusted Dynamics of COVID-19 Pandemic due to Herd Immunity in Bangladesh
Hoque, E., Islam, M. S., Amin, M. R., Das, S. K., Mitra, D. K.
10.1101/2020.09.03.20186957 — Posted: 2020-09-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).